Manufacturing Strategy

Policies to promote competition are high on the political agenda worldwide.

This book examines the progress in the biotechnology sector in India towards knowledge and innovation driven Bioeconomy. The chapters of the book review different genome editing techniques and the GM crops focusing on the emerging potential in agricultural biotechnology. Chapters on Vaccines and AI in healthcare unfold huge opportunities in medical biotechnology. The book covers the advances in biotechnology towards delivering important benefits of healthcare, particularly through the pharmaceutical industry focusing on new healthcare interventions and delivering innovations. Further, it explores the major opportunities in industrial biotechnology related to bio-pharma, biorefinery, fermentation biotechnology, and growing synergies between industry-academia. Toward the end, the book also reviews the genetic regulation and the critical role of HRD. In summary, the book emphasizes on India as a strong bio-manufacturing hub for innovative, affordable and accessible products for the society and also for global markets while describing the sector wise strategies required.

Although the authors of this book and I approach the strategic challenges of globalization from different perspectives, we've come to a similar conclusion: that the "people" imperative is often overlooked when companies decide to enter new countries or world regions. Stroh, Black, Mendenhall, and Gregersen base their assertion on extensive research and practice; mine is the product of more than 30 years in corporate leadership roles—the last two decades of which have included positions with substantial exposure to the global marketplace.

The extraordinary breakthrough management program–heralded by GE, Motorola, and AlliedSignal–that is sweeping corporate America with its unprecedented ability to achieve superior financial results.

This volume explores ways in which an organization's existing competences can be enhanced as sources of competitive advantage - either enduring or intendedly transitional.

In the early years of the 21st Century, as a result of many changes, it has become possible for the first time for tens of thousands of companies to offer manufactured products to customers across six continents. For many of these "global products", there are potentially more than a billion customers. In 2007, Wall Street hit new highs as the enormous opportunity for increased sales and profits became clear. However the new environment is not easy to manage and the risks are high.